Born from a Personal Journey.
Driven by Innovation.
MyelinZ began with a mission to transform lives through neurotechnology. Today, it’s a movement redefining brain and body performance, one breakthrough at a time.
Our Mission:
Redefining Brain Health
Dr Zied Tayeb founded MyelinZ, inspired by his mother’s fight against a neurological condition, to revolutionise brain health and help people overcome cognitive, mental, and physical challenges.
Vision:
Pioneering a New Era of Brain Health
Empowering millions to reclaim their cognitive and physical well-being.
Meet Our Leadership Team
Globally dispersed, united by one mission—to develop neurotechnology that redefines brain health and unlocks human potential.
Co-Founder & CEO
Dr Zied Tayeb
Co-Founder & CTO
Samaher Garbaya
Meet Our Experts
World-class experts guiding our mission to revolutionise brain health and unlock human potential through groundbreaking brain-computer interfaces.
Our Awards
MyelinZ at the UK Parliament (House of Commons)
MyelinZ presenting at the Belgian Ambassador’s Residence in the UK
.jpeg)
MyelinZ at Y Combinator London Event
.jpeg)
MedTech Rising Star Of The Year 2024
.jpeg)
MedTech Rising Star Of The Year 2024
.jpeg)
MyelinZ starting a collaboration with NYU Langone
.jpeg)
The R-MMS product clinical trial lanuch.
.jpeg)
The MyelinSpace product exhibition at IAC 2024.
.jpeg)
Founders touring various embassies around the world
.jpeg)
Founders touring various embassies around the world
MyelinZ Winter Retreat 2025
The MyelinZ Voyage
So Far...
- 2021
Initial technology development - Q1-2024
R&D funding & pre-seed funding - Q2-2024
Clinical trial for R-MMS (a medical device for MS) is approved and funded. - December 2024
The creation of the MyelinZ Group, launching a portfolio of three innovative products: ○ R-MMS: A medical device for MS. ○ BodyMirror: a brain health and wellbeing product, described as 'the new gym for the brain'. ○ MyelinSpace: transforming brain health in space - December 2024
Five US patents and trademarks are filed. - January 2025
MyelinZ signs three collaboration agreements with top global medical institutions to pilot BodyMirror. - Q3-2025
Q3-2025 BodyMirror Soft Launch
Disclaimer: MyelinZ products, including BodyMirror technology, are intended for research applications and personal use only. Our products are not classified as Medical Devices under EU Directive 93/42/EEC and are not designed or intended for the diagnosis or treatment of any disease.